UnknownNCT05826327
Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients
Medication studyAges 18+China
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- HangzhouSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 1, 2023
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 364
- Sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- China
- Age range
- Over 18 Years
- Official registry ID
- NCT05826327
- Official title
Show the full official title
Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression and Maternal and Neonatal Outcomes in Parturients With Prenatal Depression
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hangzhou
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Women's Hospital School Of Medicine Zhejiang University, a university.
Does this study involve medication?
Yes. The study involves medication, including Esketamine and Sufentanil.
Who can participate?
Listed age limits: from 18 years.
